Selected research
Industry Research
RNA Transcriptome Profiling Test Industry Research Report 2026
Market perspective
The global RNA Transcriptome Profiling Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the RNA Transcriptome Profiling Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the RNA Transcriptome Profiling Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the RNA Transcriptome Profiling Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of RNA Transcriptome Profiling Test include Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Merck KGaA, Eurofins Scientific and Pacific Biosciences of California, Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global RNA Transcriptome Profiling Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to RNA Transcriptome Profiling Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
RNA Transcriptome Profiling Test Market by Company
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Agilent Technologies, Inc.
QIAGEN N.V.
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc.
Merck KGaA
Eurofins Scientific
Pacific Biosciences of California, Inc.
Promega Corporation
10x Genomics
Twist Bioscience
Bruker Spatial Biology
RNA Transcriptome Profiling Test Segment by Type
Consumables
Instruments
Software
Services
RNA Transcriptome Profiling Test Segment by Application
Hospital Based Laboratories
Diagnostic Centers
Academic and Research Institutes
Contract research Organizations (CROs)
Others
RNA Transcriptome Profiling Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Transcriptome Profiling Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of RNA Transcriptome Profiling Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Transcriptome Profiling Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of RNA Transcriptome Profiling Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Consumables
- Instruments
- Software
- Services
Applications
- Hospital Based Laboratories
- Diagnostic Centers
- Academic and Research Institutes
- Contract research Organizations (CROs)
- Others
Companies covered
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- QIAGEN N.V.
- F. Hoffmann-La Roche AG
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Eurofins Scientific
- Pacific Biosciences of California, Inc.
- Promega Corporation
- 10x Genomics
- Twist Bioscience
- Bruker Spatial Biology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 RNA Transcriptome Profiling Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Consumables
- 2.2.3 Instruments
- 2.2.4 Software
- 2.2.5 Services
- 2.3 RNA Transcriptome Profiling Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Based Laboratories
- 2.3.3 Diagnostic Centers
- 2.3.4 Academic and Research Institutes
- 2.3.5 Contract research Organizations (CROs)
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 RNA Transcriptome Profiling Test Breakdown Data by Type
- 3.1 Global RNA Transcriptome Profiling Test Historic Market Size by Type (2021-2026)
- 3.2 Global RNA Transcriptome Profiling Test Forecasted Market Size by Type (2027-2032)
4 RNA Transcriptome Profiling Test Breakdown Data by Application
- 4.1 Global RNA Transcriptome Profiling Test Historic Market Size by Application (2021-2026)
- 4.2 Global RNA Transcriptome Profiling Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global RNA Transcriptome Profiling Test Market Perspective (2021-2032)
- 5.2 Global RNA Transcriptome Profiling Test Growth Trends by Region
- 5.2.1 Global RNA Transcriptome Profiling Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 RNA Transcriptome Profiling Test Historic Market Size by Region (2021-2026)
- 5.2.3 RNA Transcriptome Profiling Test Forecasted Market Size by Region (2027-2032)
- 5.3 RNA Transcriptome Profiling Test Market Dynamics
- 5.3.1 RNA Transcriptome Profiling Test Industry Trends
- 5.3.2 RNA Transcriptome Profiling Test Market Drivers
- 5.3.3 RNA Transcriptome Profiling Test Market Challenges
- 5.3.4 RNA Transcriptome Profiling Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top RNA Transcriptome Profiling Test Players by Revenue
- 6.1.1 Global Top RNA Transcriptome Profiling Test Players by Revenue (2021-2026)
- 6.1.2 Global RNA Transcriptome Profiling Test Revenue Market Share by Players (2021-2026)
- 6.2 Global RNA Transcriptome Profiling Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of RNA Transcriptome Profiling Test Head Office and Area Served
- 6.4 Global RNA Transcriptome Profiling Test Players, Product Type & Application
- 6.5 Global RNA Transcriptome Profiling Test Manufacturers Established Date
- 6.6 Global RNA Transcriptome Profiling Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America RNA Transcriptome Profiling Test Market Size (2021-2032)
- 7.2 North America RNA Transcriptome Profiling Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 7.4 North America RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe RNA Transcriptome Profiling Test Market Size (2021-2032)
- 8.2 Europe RNA Transcriptome Profiling Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 8.4 Europe RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific RNA Transcriptome Profiling Test Market Size (2021-2032)
- 9.2 Asia-Pacific RNA Transcriptome Profiling Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America RNA Transcriptome Profiling Test Market Size (2021-2032)
- 10.2 South America RNA Transcriptome Profiling Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 10.4 South America RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa RNA Transcriptome Profiling Test Market Size (2021-2032)
- 11.2 Middle East & Africa RNA Transcriptome Profiling Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific, Inc.
- 12.1.1 Thermo Fisher Scientific, Inc. Company Information
- 12.1.2 Thermo Fisher Scientific, Inc. Business Overview
- 12.1.3 Thermo Fisher Scientific, Inc. Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 12.1.5 Thermo Fisher Scientific, Inc. Recent Developments
- 12.2 Illumina, Inc.
- 12.2.1 Illumina, Inc. Company Information
- 12.2.2 Illumina, Inc. Business Overview
- 12.2.3 Illumina, Inc. Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.2.4 Illumina, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 12.2.5 Illumina, Inc. Recent Developments
- 12.3 Agilent Technologies, Inc.
- 12.3.1 Agilent Technologies, Inc. Company Information
- 12.3.2 Agilent Technologies, Inc. Business Overview
- 12.3.3 Agilent Technologies, Inc. Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.3.4 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 12.3.5 Agilent Technologies, Inc. Recent Developments
- 12.4 QIAGEN N.V.
- 12.4.1 QIAGEN N.V. Company Information
- 12.4.2 QIAGEN N.V. Business Overview
- 12.4.3 QIAGEN N.V. Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.4.4 QIAGEN N.V. RNA Transcriptome Profiling Test Product Portfolio
- 12.4.5 QIAGEN N.V. Recent Developments
- 12.5 F. Hoffmann-La Roche AG
- 12.5.1 F. Hoffmann-La Roche AG Company Information
- 12.5.2 F. Hoffmann-La Roche AG Business Overview
- 12.5.3 F. Hoffmann-La Roche AG Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.5.4 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Product Portfolio
- 12.5.5 F. Hoffmann-La Roche AG Recent Developments
- 12.6 Bio-Rad Laboratories, Inc.
- 12.6.1 Bio-Rad Laboratories, Inc. Company Information
- 12.6.2 Bio-Rad Laboratories, Inc. Business Overview
- 12.6.3 Bio-Rad Laboratories, Inc. Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.6.4 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 12.6.5 Bio-Rad Laboratories, Inc. Recent Developments
- 12.7 Merck KGaA
- 12.7.1 Merck KGaA Company Information
- 12.7.2 Merck KGaA Business Overview
- 12.7.3 Merck KGaA Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.7.4 Merck KGaA RNA Transcriptome Profiling Test Product Portfolio
- 12.7.5 Merck KGaA Recent Developments
- 12.8 Eurofins Scientific
- 12.8.1 Eurofins Scientific Company Information
- 12.8.2 Eurofins Scientific Business Overview
- 12.8.3 Eurofins Scientific Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.8.4 Eurofins Scientific RNA Transcriptome Profiling Test Product Portfolio
- 12.8.5 Eurofins Scientific Recent Developments
- 12.9 Pacific Biosciences of California, Inc.
- 12.9.1 Pacific Biosciences of California, Inc. Company Information
- 12.9.2 Pacific Biosciences of California, Inc. Business Overview
- 12.9.3 Pacific Biosciences of California, Inc. Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.9.4 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 12.9.5 Pacific Biosciences of California, Inc. Recent Developments
- 12.10 Promega Corporation
- 12.10.1 Promega Corporation Company Information
- 12.10.2 Promega Corporation Business Overview
- 12.10.3 Promega Corporation Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.10.4 Promega Corporation RNA Transcriptome Profiling Test Product Portfolio
- 12.10.5 Promega Corporation Recent Developments
- 12.11 10x Genomics
- 12.11.1 10x Genomics Company Information
- 12.11.2 10x Genomics Business Overview
- 12.11.3 10x Genomics Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.11.4 10x Genomics RNA Transcriptome Profiling Test Product Portfolio
- 12.11.5 10x Genomics Recent Developments
- 12.12 Twist Bioscience
- 12.12.1 Twist Bioscience Company Information
- 12.12.2 Twist Bioscience Business Overview
- 12.12.3 Twist Bioscience Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.12.4 Twist Bioscience RNA Transcriptome Profiling Test Product Portfolio
- 12.12.5 Twist Bioscience Recent Developments
- 12.13 Bruker Spatial Biology
- 12.13.1 Bruker Spatial Biology Company Information
- 12.13.2 Bruker Spatial Biology Business Overview
- 12.13.3 Bruker Spatial Biology Revenue in RNA Transcriptome Profiling Test Business (2021-2026)
- 12.13.4 Bruker Spatial Biology RNA Transcriptome Profiling Test Product Portfolio
- 12.13.5 Bruker Spatial Biology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst